Takeda CEO Christophe Weber to step down following prolonged drop in company shares

Taking stock of the drug industry, from the lab to the medicine chest

January 30, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

BEHROUZ MEHRI/AFP via Getty Images STAT+ | Takeda CEO Christophe Weber to step down following prolonged drop in company shares Julie Kim, currently president of Takeda's U.S. business unit, will succeed him, making her one of the few female chief executives in the pharma industry. By Allison DeAngelis and Matthew Herper STAT+ | MASH drugs reach a meaningful tipping point for patients and investors Akero's success in reversing cirrhosis follows that of Madrigal, making analysts and investors bullish on drugs to treat severe liver disease. By Adam Feuerstein STAT+ | How AI helps drug developers skirt pharma's 'dirty little secret' Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process more efficient. By Brittany Trang

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser